CSat Investment Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $16K | Buy |
195
+68
| +54% | +$5.58K | 0.01% | 405 |
|
2020
Q4 | $12K | Sell |
127
-3,437
| -96% | -$325K | 0.01% | 415 |
|
2020
Q3 | $284K | Buy |
3,564
+381
| +12% | +$30.4K | 0.03% | 226 |
|
2020
Q2 | $220K | Buy |
3,183
+318
| +11% | +$22K | 0.03% | 286 |
|
2020
Q1 | $180K | Buy |
2,865
+1,044
| +57% | +$65.6K | 0.04% | 255 |
|
2019
Q4 | $141K | Buy |
1,821
+471
| +35% | +$36.5K | 0.04% | 289 |
|
2019
Q3 | $99K | Buy |
1,350
+138
| +11% | +$10.1K | 0.03% | 314 |
|
2019
Q2 | $75K | Buy |
1,212
+1,065
| +724% | +$65.9K | 0.03% | 351 |
|
2019
Q1 | $9K | Buy |
147
+6
| +4% | +$367 | ﹤0.01% | 440 |
|
2018
Q4 | $7K | Hold |
141
| – | – | ﹤0.01% | 453 |
|
2018
Q3 | $8K | Buy |
141
+21
| +18% | +$1.19K | ﹤0.01% | 405 |
|
2018
Q2 | $6K | Buy |
+120
| New | +$6K | ﹤0.01% | 433 |
|